What is Parallel Bio worth?
$71.5Mlast known valuation
Parallel Bio last raised $20.0M in its Later Stage VC (Series A1) (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Parallel Bio
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC (Series A1) | $20.0M | ▮ | ▮ |
| Dec 2022 | Seed Round | $4.3M | ▮ | ▮ |
How Parallel Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Parallel Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Parallel Bio worth?
- Parallel Bio's last known valuation is $71.5M.
- How much has Parallel Bio raised?
- Parallel Bio has raised $24.6M in total funding across 2 recorded rounds.
- When did Parallel Bio last raise?
- Parallel Bio last raised in Jun 2025 (Later Stage VC (Series A1)), raising $20.0M.